Topokine Overview
- Year Founded
-
2010

- Status
-
Acquired/Merged
- Employees
-
2

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$346M
Topokine General Information
Description
Developer of therapies for dermatology and medical aesthetics. The company develops topical medications for non-invasive contouring of the face and body. It develops non-invasive therapies for subcutaneous fat disorders.
Contact Information
Website
www.topokinetherapeutics.comCorporate Office
- 60 South Street
- Suite 1120
- Boston, MA 02111
- United States
Corporate Office
- 60 South Street
- Suite 1120
- Boston, MA 02111
- United States
Topokine Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 21-Apr-2016 | $346M | Completed | Clinical Trials - Phase 2 | ||
2. Early Stage VC (Series A) | 02-Apr-2014 | Completed | Clinical Trials - Phase 2 | |||
1. Early Stage VC | 22-Jan-2013 | Completed | Clinical Trials - Phase 1 |
Topokine Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
Topokine Patents
Topokine Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-10188661-B2 | Topical dosage regimen | Active | 27-Jun-2014 | ||
US-20170202852-A1 | Topical dosage regimen | Active | 27-Jun-2014 | ||
US-10869874-B2 | Methods and compositions for topical delivery of prostaglandins to subcutaneous fat | Active | 15-May-2013 | ||
US-20160067263-A1 | Methods and compositions for topical delivery of prostaglandins to subcutaneous fat | Active | 15-May-2013 | ||
US-20180169111-A1 | Methods and compositions for topical delivery of prostaglandins to subcutaneous fat | Active | 15-May-2013 | A61K31/5575 |
Topokine Signals
Topokine Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Schooner Capital | Growth/Expansion | Minority |
Topokine FAQs
-
When was Topokine founded?
Topokine was founded in 2010.
-
Where is Topokine headquartered?
Topokine is headquartered in Boston, MA.
-
What is the size of Topokine?
Topokine has 2 total employees.
-
What industry is Topokine in?
Topokine’s primary industry is Drug Discovery.
-
Is Topokine a private or public company?
Topokine is a Private company.
-
What is the current valuation of Topokine?
The current valuation of Topokine is
. -
What is Topokine’s current revenue?
The current revenue for Topokine is
. -
How much funding has Topokine raised over time?
Topokine has raised $3.98M.
-
Who are Topokine’s investors?
Schooner Capital has invested in Topokine.
-
When was Topokine acquired?
Topokine was acquired on 21-Apr-2016.
-
Who acquired Topokine?
Topokine was acquired by Allergan.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »